Voxel S.A.

WSE:VOX Voorraadrapport

Marktkapitalisatie: zł1.2b

Voxel Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Voxel has been growing earnings at an average annual rate of 24.7%, while the Healthcare industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 14.9% per year. Voxel's return on equity is 29.5%, and it has net margins of 18.8%.

Belangrijke informatie

24.7%

Groei van de winst

24.8%

Groei van de winst per aandeel

Healthcare Groei van de industrie13.7%
Inkomstengroei14.9%
Rendement op eigen vermogen29.5%
Nettomarge18.8%
Volgende winstupdate25 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Further Upside For Voxel S.A. (WSE:VOX) Shares Could Introduce Price Risks After 39% Bounce

Dec 18
Further Upside For Voxel S.A. (WSE:VOX) Shares Could Introduce Price Risks After 39% Bounce

A Look At The Intrinsic Value Of Voxel S.A. (WSE:VOX)

Dec 13
A Look At The Intrinsic Value Of Voxel S.A. (WSE:VOX)

Voxel (WSE:VOX) Is Achieving High Returns On Its Capital

Nov 24
Voxel (WSE:VOX) Is Achieving High Returns On Its Capital

Estimating The Intrinsic Value Of Voxel S.A. (WSE:VOX)

Jun 08
Estimating The Intrinsic Value Of Voxel S.A. (WSE:VOX)

Voxel (WSE:VOX) Seems To Use Debt Quite Sensibly

May 20
Voxel (WSE:VOX) Seems To Use Debt Quite Sensibly

Voxel S.A. (WSE:VOX) Is An Attractive Dividend Stock - Here's Why

Mar 05
Voxel S.A. (WSE:VOX) Is An Attractive Dividend Stock - Here's Why

Voxel (WSE:VOX) Has A Somewhat Strained Balance Sheet

Feb 05
Voxel (WSE:VOX) Has A Somewhat Strained Balance Sheet

Should You Be Impressed By Voxel's (WSE:VOX) Returns on Capital?

Dec 31
Should You Be Impressed By Voxel's (WSE:VOX) Returns on Capital?

What Is The Ownership Structure Like For Voxel S.A. (WSE:VOX)?

Dec 15
What Is The Ownership Structure Like For Voxel S.A. (WSE:VOX)?

Opbrengsten en kosten

Hoe Voxel geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

WSE:VOX Opbrengsten, kosten en inkomsten (PLN Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2447689260
31 Mar 2444486250
31 Dec 2342481240
30 Sep 2344969240
30 Jun 2341962240
31 Mar 2340347240
31 Dec 2241544250
30 Sep 2240456250
30 Jun 2239950250
31 Mar 2243165250
31 Dec 2144371250
30 Sep 2145166260
30 Jun 2144468260
31 Mar 2138947270
31 Dec 2032834270
30 Sep 2025721250
30 Jun 2021915230
31 Mar 2021322230
31 Dec 1921223220
30 Sep 1921025220
30 Jun 1920026210
31 Mar 1918724210
31 Dec 1817023190
30 Sep 1816124190
30 Jun 1815522190
31 Mar 1815120190
31 Dec 1715220190
30 Sep 1713315180
30 Jun 1712512180
31 Mar 1712613180
31 Dec 1612111190
30 Sep 1612911210
30 Jun 1613512200
31 Mar 1613513200
31 Dec 1513214180
30 Sep 151217170
30 Jun 151152180
31 Mar 15108-3190
31 Dec 14103-5200
30 Sep 1495-1210
30 Jun 141030220
31 Mar 141053210
31 Dec 131033210

Kwaliteitswinsten: VOX has high quality earnings.

Groeiende winstmarge: VOX's current net profit margins (18.8%) are higher than last year (14.7%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: VOX's earnings have grown significantly by 24.7% per year over the past 5 years.

Versnelling van de groei: VOX's earnings growth over the past year (45.1%) exceeds its 5-year average (24.7% per year).

Winst versus industrie: VOX earnings growth over the past year (45.1%) did not outperform the Healthcare industry 53%.

Rendement op eigen vermogen

Hoge ROE: VOX's Return on Equity (29.5%) is considered high.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y